Meeting to be held in New York on November 30 hosted by Oppenheimer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GILD:
- Cabaletta Bio, Gracell slide as FDA probes risk of CAR T cell immunotherapies
- FDA probing risk of T-cell malignancy following CAR T cell immunotherapies
- Gilead management to meet with Oppenheimer
- Aurinia strength may be related to Gilead suspicion, says Gordon Haskett
- Hookipa Pharma announces FDA clearance of IND application for HB-500